Precision radiation offers new hope for recurrent prostate cancer
NCT ID NCT03312972
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 20 times
Summary
This study tests a focused radiation technique called HDR brachytherapy for men whose prostate cancer has returned after earlier radiation treatment. The treatment places a temporary radioactive source directly into the cancerous area, sparing healthy tissue. The goal is to see if this approach is safe and effective for controlling the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY RECURRENT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
University of Virginia School of Medicine
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.